Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Ecotoxicology and Environmental Safety|June 4, 2025
Biological ageing mediates the associations between urinary metals and metabolic dysfunction-associated steatotic liver diseaseYin-Ping Wu, Jin Feng, Yuan-Yuan Zhang, et al.
Clinics and Research in Hepatology and Gastroenterology|February 13, 2017
Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis BMing-Ming Tian, Yu-Chen Fan, Jing Zhao, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 30, 2022
Hypermethylation of thymosin β4 predicts a poor prognosis for patients with acute-on-chronic hepatitis B liver failureHe Wang, Yan-Ping Yin, Zhen-Li Wang, et al.
The Tohoku Journal of Experimental Medicine|November 26, 2020
Diagnostic Value of the Hypomethylation of the WISP1 Promoter in Patients with Hepatocellular Carcinoma Associated with Hepatitis B VirusLa-Mei Chen, Lin Xiang, Wei-Juan Sun, et al.
The Tohoku Journal of Experimental Medicine|March 21, 2014
Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinomaYang Yang, Yu-Chen Fan, Shuai Gao, et al.
Molecular Biology Reports|June 22, 2012
Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysisKe-Qing Shi, Yu-Chen Fan, Wen-Yue Liu, et al.
Pageof 15